Terms: = Sarcomas AND NOTCH2, Q04721, 4853, ENSG00000134250, AGS2, hN2 AND Treatment
5 results:
1. DNMT1 determines osteosarcoma cell resistance to apoptosis by associatively modulating DNA and mRNA cytosine-5 methylation.
Shao D; Liu C; Wang Y; Lin J; Cheng X; Han P; Li Z; Jian D; Nie J; Jiang M; Wei Y; Xing J; Guo Z; Wang W; Yi X; Tang H
FASEB J; 2023 Dec; 37(12):e23284. PubMed ID: 37905981
[TBL] [Abstract] [Full Text] [Related]
2. The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study.
da Costa LT; Dos Anjos LG; Kagohara LT; Torrezan GT; De Paula CAA; Baracat EC; Carraro DM; Carvalho KC
Clinics (Sao Paulo); 2021; 76():e2324. PubMed ID: 33503190
[TBL] [Abstract] [Full Text] [Related]
3. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract] [Full Text] [Related]
4. Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation.
Tanaka M; Setoguchi T; Hirotsu M; Gao H; Sasaki H; Matsunoshita Y; Komiya S
Br J Cancer; 2009 Jun; 100(12):1957-65. PubMed ID: 19455146
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Qazi GN; Sanyal U
J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
[TBL] [Abstract] [Full Text] [Related]
